Breaking News Instant updates and real-time market news.

ARNC

Arconic

$29.33 /

-0.675 (-2.25%)

, BA

Boeing

$324.11 /

-7.89 (-2.38%)

08:44
01/21/20
01/21
08:44
01/21/20
08:44

Arconic could lose up to $400M of commercial aerospace revenue, says Longbow

Longbow analyst Chris Olin says he believes Arconic (ARNC) could lose up to $400M of previously expected commercial aerospace revenue in CY20. In a research note to investors, Olin, who made no change to his Neutral rating, says recent communications between Boeing (BA) and its main global suppliers suggests the OEM is likely to issue conservative 737 production targets for CY20, starting at 21/month followed by a shift to 28/month. He assumes assume Arconic has $1.6M of revenue content on the MAX platform. Additionally, he says that should CFM International formally lower its LEAP production outlook by 600 engines for CY20 and beyond, it could negatively impact the higher margin business units within Arconic's EP&F segment, including Power & Propulsion.

ARNC

Arconic

$29.33 /

-0.675 (-2.25%)

BA

Boeing

$324.11 /

-7.89 (-2.38%)

  • 27

    Jan

  • 29

    Jan

ARNC Arconic
$29.33 /

-0.675 (-2.25%)

01/16/20 Benchmark
Arconic initiated with a Hold at Benchmark
12/03/19 JPMorgan
Arconic price target raised to $36 from $30 at JPMorgan
11/11/19 Barclays
Arconic price target raised to $35 from $31 at Barclays
10/15/19 Credit Suisse
Arconic price target raised to $34 from $28 at Credit Suisse
BA Boeing
$324.11 /

-7.89 (-2.38%)

01/21/20 Bernstein
Investors expect Boeing to resume MAX deliveries in Q2, says Bernstein
01/17/20 Canaccord
Boeing price target lowered to $350 from $370 at Canaccord
01/15/20 BofA
Spirit AeroSystems downgraded to Neutral from Buy at BofA
01/09/20
Fly Intel: Top five analyst downgrades

TODAY'S FREE FLY STORIES

Conference/Events
The Cato Institute to hold a conference » 08:16
02/19/20
02/19
08:16
02/19/20
08:16

Cato Institute Policy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
Aspen Group reports 1,746 enrollments in Q3 » 08:16
02/19/20
02/19
08:16
02/19/20
08:16
ASPU

Aspen Group

$9.48 /

-0.22 (-2.27%)

Aspen Group announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Oppenheimer to hold a summit » 08:15
02/19/20
02/19
08:15
02/19/20
08:15

Blockchain Summit:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

General news
Housing Starts to be reported at 08:30 » 08:15
02/19/20
02/19
08:15
02/19/20
08:15

January Housing Starts…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
Housing Starts Permits to be reported at 08:30 » 08:15
02/19/20
02/19
08:15
02/19/20
08:15

January Housing Starts…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

General news
Cleveland Federal Reserve Bank President Loretta Mester Speech to be released at 08:30  08:15
02/19/20
02/19
08:15
02/19/20
08:15
 
General news
PPI-FD less food & energy to be reported at 08:30 » 08:15
02/19/20
02/19
08:15
02/19/20
08:15

January PPI-FD less food…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

General news
Cleveland Federal Reserve Bank President Loretta Mester Speech to be released at 08:30  08:15
02/19/20
02/19
08:15
02/19/20
08:15
 
General news
PPI-FD to be reported at 08:30 » 08:15
02/19/20
02/19
08:15
02/19/20
08:15

January PPI-FD will be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Earnings
Seaspan reports Q4 EPS 24c, consensus 22c » 08:14
02/19/20
02/19
08:14
02/19/20
08:14
SSW

Seaspan

$12.12 /

-0.1 (-0.82%)

Reports Q4 revenue $288M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Chemed price target raised to $525 from $535 at Oppenheimer » 08:14
02/19/20
02/19
08:14
02/19/20
08:14
CHE

Chemed

$492.13 /

+2.12 (+0.43%)

Oppenheimer analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
TransUnion price target raised to $105 from $94 at Deutsche Bank » 08:13
02/19/20
02/19
08:13
02/19/20
08:13
TRU

TransUnion

$98.16 /

+ (+0.00%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Karyopharm announces FDA acceptance of sNDA for XPOVIO » 08:13
02/19/20
02/19
08:13
02/19/20
08:13
KPTI

Karyopharm

$16.34 /

+0.95 (+6.17%)

Karyopharm Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Jeld-Wen post-earnings selloff overdone, says Jefferies » 08:12
02/19/20
02/19
08:12
02/19/20
08:12
JELD

Jeld-Wen

$22.35 /

-2.855 (-11.33%)

Jefferies analyst Philip…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Choice Hotels price target raised to $95 from $85 at Deutsche Bank » 08:12
02/19/20
02/19
08:12
02/19/20
08:12
CHH

Choice Hotels

$105.67 /

+0.91 (+0.87%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Eton says FDA requests changes to ET-105 Dosage and Administration section » 08:12
02/19/20
02/19
08:12
02/19/20
08:12
ETON

Eton Pharmaceuticals

$7.31 /

+0.29 (+4.13%)

Eton Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
DarioHealth' digital therapeutics platform shows positive diabetes management » 08:12
02/19/20
02/19
08:12
02/19/20
08:12
DRIO

DarioHealth

$9.23 /

-0.02 (-0.22%)

DarioHealth presented a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Envestnet downgraded to Neutral from Buy at DA Davidson » 08:11
02/19/20
02/19
08:11
02/19/20
08:11
ENV

Envestnet

$87.70 /

+1.07 (+1.24%)

DA Davidson analyst Peter…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Oppenheimer bullish on Prevail Therapeutics, initiates with an Outperform » 08:11
02/19/20
02/19
08:11
02/19/20
08:11
PRVL

Prevail Therapeutics

$17.00 /

-0.47 (-2.69%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Immutep announces interim data from ongoing Phase II TACTI-002 study » 08:10
02/19/20
02/19
08:10
02/19/20
08:10
IMMP

Immutep

$3.02 /

+0.37 (+13.96%)

Immutep announces…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Recommendations
Alteryx price target raised to $202 from $150 at Citi » 08:10
02/19/20
02/19
08:10
02/19/20
08:10
AYX

Alteryx

$156.69 /

-1.14 (-0.72%)

Citi analyst Tyler Radke…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
The ASTCT and CIBMTR to hold a joint meeting » 08:09
02/19/20
02/19
08:09
02/19/20
08:09
ABBV

AbbVie

$93.60 /

-0.47 (-0.50%)

, ADPT

Adaptive Biotechnologies

$31.75 /

+0.29 (+0.92%)

, AMGN

Amgen

$221.74 /

-1.58 (-0.71%)

, ATNM

Actinium Pharmaceuticals

$0.25 /

-0.0132 (-5.09%)

, ATRA

Atara Biotherapeutics

$14.55 /

+0.3 (+2.11%)

, AZN

AstraZeneca

$49.17 /

+1.3 (+2.72%)

, BLUE

Bluebird Bio

$88.16 /

-0.98 (-1.10%)

, CDNA

CareDx

$27.15 /

+0.48 (+1.80%)

, CDTX

Cidara Therapeutics

$3.08 /

+0.1 (+3.36%)

, CELG

Bought by BMY

$0.00 /

+ (+0.00%)

, EQ

Equillium

$5.04 /

+0.06 (+1.20%)

, GMDA

Gamida Cell

$4.76 /

+0.035 (+0.74%)

, GSK

GlaxoSmithKline

$43.55 /

-0.19 (-0.43%)

, HUM

Humana

$372.26 /

-3.815 (-1.01%)

, INCY

Incyte

$79.25 /

+0.83 (+1.06%)

, JAZ

Jazz Technologies

$0.00 /

+ (+0.00%)

, KDMN

Kadmon

$4.85 /

+0.325 (+7.19%)

, MGTA

Magenta Therapeutics

$12.56 /

+0.2 (+1.62%)

, MRK

Merck

$82.46 /

-0.18 (-0.22%)

, NVS

Novartis

$97.21 /

-0.465 (-0.48%)

, PFE

Pfizer

$36.31 /

-0.18 (-0.49%)

, RCKT

Rocket Pharmaceuticals

$25.18 /

+1.18 (+4.92%)

, SGEN

Seattle Genetics

$119.99 /

+1.9 (+1.61%)

, SNY

Sanofi

$51.14 /

+1.21 (+2.42%)

, TAK

Takeda Pharmaceutical

$19.15 /

-0.29 (-1.49%)

American Society for…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Tencent Music downgraded to Perform at Oppenheimer » 08:08
02/19/20
02/19
08:08
02/19/20
08:08
TME

Tencent Music

$12.68 /

-0.46 (-3.50%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Groupon says Q4 results disappointing 'on nearly every measure' » 08:08
02/19/20
02/19
08:08
02/19/20
08:08
GRPN

Groupon

$3.02 /

+0.175 (+6.15%)

Comments taken from Q4…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Signature Bank initiated with a Neutral at DA Davidson » 08:08
02/19/20
02/19
08:08
02/19/20
08:08
SBNY

Signature Bank

$144.32 /

+0.03 (+0.02%)

DA Davidson analyst David…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.